2'3'-cGAMP (sodium salt): A Benchmark STING Agonist for Innate Immunity Research

Executive Summary: 2'3'-cGAMP (sodium salt) is an endogenous cyclic dinucleotide synthesized by cGAS in response to cytosolic double-stranded DNA, directly binding and activating the STING protein with a dissociation constant (Kd) of 3.79 nM, higher than other cyclic dinucleotides (Zhang et al., 2025, DOI). Its activation of the cGAS-STING pathway triggers TBK1 and IRF3 signaling, culminating in robust type I interferon (IFN-β) production in mammalian cells. The molecule is central to immunology, inflammation, cancer, and antiviral research due to its high selectivity and potency. APExBIO's 2'3'-cGAMP (sodium salt) (SKU: B8362) is a well-characterized, water-soluble research standard enabling reproducible STING pathway assays (product page). Recent clinical and mechanistic studies highlight its role in tumor vasculature normalization and immune cell infiltration, positioning it as a critical tool for translational research (DOI).

Biological Rationale

2'3'-cGAMP (sodium salt) is a naturally occurring cyclic dinucleotide messenger in mammals. It is produced by cyclic GMP-AMP synthase (cGAS) upon sensing cytosolic double-stranded DNA, a hallmark of viral infection, cellular stress, or DNA damage (Zhang et al., 2025). The molecule serves as a second messenger, rapidly diffusing within cells to amplify innate immune signaling. Activation of the STING (stimulator of interferon genes) pathway by 2'3'-cGAMP is a key event in the induction of type I interferons, which are crucial for antiviral defense, tumor immunosurveillance, and immunotherapy response (internal). Unlike microbial cyclic dinucleotides (CDNs), 2'3'-cGAMP is specific to vertebrates and exhibits higher affinity for human STING isoforms (APExBIO).

Mechanism of Action of 2'3'-cGAMP (sodium salt)

Upon generation by cGAS, 2'3'-cGAMP binds directly to the CDN-binding domain of the STING protein in the endoplasmic reticulum (ER) membrane. This binding triggers conformational changes, leading to STING activation and trafficking from the ER to the Golgi apparatus. Activated STING recruits and activates TANK-binding kinase 1 (TBK1), which phosphorylates the transcription factor IRF3. Phosphorylated IRF3 translocates to the nucleus, inducing transcription of IFN-β and other interferon-stimulated genes (ISGs) (Zhang et al., 2025). Notably, STING activation is also linked to nuclear factor-κB (NF-κB) signaling and palmitoylation at cysteine 88/91, facilitating efficient immune response (internal). 2'3'-cGAMP uniquely induces robust IFN-I signaling in multiple cell types, including endothelial cells, dendritic cells, and macrophages, highlighting its broad utility in innate immunity research.

Evidence & Benchmarks

• 2'3'-cGAMP binds human STING with a dissociation constant (Kd) of 3.79 nM in vitro (Zhang et al., 2025, DOI).
• STING activation by 2'3'-cGAMP triggers TBK1 recruitment and IRF3 phosphorylation within minutes at 37°C in mammalian cell lysates (Zhang et al., 2025, DOI).
• Intratumoral injection of 2'3'-cGAMP normalizes tumor vasculature and significantly increases CD8+ T cell infiltration in murine cancer models (Zhang et al., 2025, DOI).
• 2'3'-cGAMP-induced STING activation in endothelium is essential for antitumor efficacy, with loss of endothelial STING abrogating vascular normalization and immune infiltration (Zhang et al., 2025, DOI).
• Water solubility of ≥7.56 mg/mL at room temperature (APExBIO datasheet, product page).
• 2'3'-cGAMP is insoluble in ethanol and DMSO, requiring aqueous buffers for in vitro assays (APExBIO datasheet, product page).
• Storage at -20°C preserves compound stability for at least 12 months under desiccated conditions (APExBIO datasheet, product page).

Applications, Limits & Misconceptions

2'3'-cGAMP (sodium salt) is widely used in:

• Characterizing STING pathway activation and innate immune responses in mammalian cells (internal).
• Screening STING-targeted drug candidates and immunomodulators.
• Modeling tumor microenvironment and vascular normalization in cancer research (internal).
• Investigating antiviral innate immunity and host-pathogen interactions.

This article extends recent analyses (related internal) by synthesizing clinical and mechanistic benchmarks, clarifying product-specific workflow details, and addressing experimental boundaries.

Common Pitfalls or Misconceptions

• 2'3'-cGAMP (sodium salt) is ineffective in models lacking functional STING protein (e.g., STING knockout or mutant cells).
• It does not activate non-STING cytosolic DNA sensors such as AIM2 or DAI.
• The compound is not a direct antimicrobial; its action is immunomodulatory, not cytotoxic.
• Results from murine models may not fully extrapolate to human immune responses due to STING isoform differences.
• DMSO and ethanol are unsuitable solvents; use only aqueous buffers to avoid precipitation and loss of activity (APExBIO).

Workflow Integration & Parameters

For experimental reproducibility, use 2'3'-cGAMP (sodium salt) as per APExBIO's specifications (SKU: B8362). Prepare working solutions in sterile water or PBS at concentrations up to 7.56 mg/mL. For in vitro assays, typical concentrations range from 0.1 to 10 μM, with incubation at 37°C for 15–60 min depending on cell type (internal). For in vivo tumor models, intratumoral or intravenous doses are determined by animal weight and experimental endpoints. Store lyophilized powder at -20°C in a desiccated container to prevent hydrolysis. Confirm compound integrity via HPLC or mass spectrometry if stored for extended periods. For troubleshooting assay reproducibility, see APExBIO's detailed protocol guidance and scenario-driven workflow article, which clarifies design and analysis best practices for innate immunity studies.

Conclusion & Outlook

2'3'-cGAMP (sodium salt) is a reference STING agonist with superior binding affinity, selectivity, and water solubility, making it indispensable for dissecting cGAS-STING signaling. Its validated role in tumor vasculature normalization and immune cell recruitment highlights translational potential in immunotherapy and antiviral research. As clinical applications of STING agonists advance, rigorous mechanistic studies using standardized reagents like APExBIO's B8362 will underpin future therapeutic innovations. For more information or procurement, refer to the official product page.